Guanfacine (Page 7 of 7)

PACKAGE/LABEL PRINCIPAL DISPLAY PANEL

Generic Section

NDC 63304-924-01

Guanfacine Extended-Release Tablets, USP

1 mg

Tablets should not be crushed, chewed or broken before swallowing.

Rx only

100 Tablets OHM
Guanfacine-1 mg
(click image for full-size original)

Generic Section

NDC 63304-925-01

Guanfacine Extended-Release Tablets, USP

2 mg

Tablets should not be crushed, chewed or broken before swallowing.

Rx only

100 Tablets OHM
Guanfacine-2 mg
(click image for full-size original)

Generic Section

NDC 63304-926-01

Guanfacine Extended-Release Tablets, USP

3 mg

Tablets should not be crushed, chewed or broken before swallowing.

Rx only

100 Tablets OHM
Guanfacine- 3 mg
(click image for full-size original)

Generic Section

NDC 63304-927-01

Guanfacine Extended-Release Tablets, USP

4 mg

Tablets should not be crushed, chewed or broken before swallowing.

Rx only

100 Tablets OHM
Guanfacine- 4 mg
(click image for full-size original)
GUANFACINE
guanfacine tablet, extended release
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:63304-924
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
GUANFACINE HYDROCHLORIDE (GUANFACINE) GUANFACINE 1 mg
Inactive Ingredients
Ingredient Name Strength
LACTOSE MONOHYDRATE
FUMARIC ACID
METHACRYLIC ACID — ETHYL ACRYLATE COPOLYMER (1:1) TYPE A
GLYCERYL DIBEHENATE
SILICON DIOXIDE
MICROCRYSTALLINE CELLULOSE
HYPROMELLOSE, UNSPECIFIED
POVIDONE, UNSPECIFIED
Product Characteristics
Color white (white to off white) Score no score
Shape ROUND Size 8mm
Flavor Imprint Code RJ70
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:63304-924-30 30 TABLET, EXTENDED RELEASE in 1 BOTTLE None
2 NDC:63304-924-01 100 TABLET, EXTENDED RELEASE in 1 BOTTLE None
3 NDC:63304-924-05 500 TABLET, EXTENDED RELEASE in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA205689 08/17/2018
GUANFACINE
guanfacine tablet, extended release
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:63304-925
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
GUANFACINE HYDROCHLORIDE (GUANFACINE) GUANFACINE 2 mg
Inactive Ingredients
Ingredient Name Strength
LACTOSE MONOHYDRATE
FUMARIC ACID
METHACRYLIC ACID — ETHYL ACRYLATE COPOLYMER (1:1) TYPE A
GLYCERYL DIBEHENATE
SILICON DIOXIDE
MICROCRYSTALLINE CELLULOSE
HYPROMELLOSE, UNSPECIFIED
POVIDONE, UNSPECIFIED
Product Characteristics
Color white (white to off white) Score no score
Shape OVAL Size 14mm
Flavor Imprint Code RJ71
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:63304-925-30 30 TABLET, EXTENDED RELEASE in 1 BOTTLE None
2 NDC:63304-925-01 100 TABLET, EXTENDED RELEASE in 1 BOTTLE None
3 NDC:63304-925-05 500 TABLET, EXTENDED RELEASE in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA205689 08/17/2018
GUANFACINE
guanfacine tablet, extended release
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:63304-926
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
GUANFACINE HYDROCHLORIDE (GUANFACINE) GUANFACINE 3 mg
Inactive Ingredients
Ingredient Name Strength
LACTOSE MONOHYDRATE
FUMARIC ACID
METHACRYLIC ACID — ETHYL ACRYLATE COPOLYMER (1:1) TYPE A
FD&C BLUE NO. 2
FERRIC OXIDE YELLOW
SILICON DIOXIDE
GLYCERYL DIBEHENATE
MICROCRYSTALLINE CELLULOSE
HYPROMELLOSE, UNSPECIFIED
POVIDONE, UNSPECIFIED
Product Characteristics
Color green Score no score
Shape ROUND Size 8mm
Flavor Imprint Code RJ72
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:63304-926-30 30 TABLET, EXTENDED RELEASE in 1 BOTTLE None
2 NDC:63304-926-01 100 TABLET, EXTENDED RELEASE in 1 BOTTLE None
3 NDC:63304-926-05 500 TABLET, EXTENDED RELEASE in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA205689 08/17/2018
GUANFACINE
guanfacine tablet, extended release
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:63304-927
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
GUANFACINE HYDROCHLORIDE (GUANFACINE) GUANFACINE 4 mg
Inactive Ingredients
Ingredient Name Strength
LACTOSE MONOHYDRATE
FUMARIC ACID
METHACRYLIC ACID — ETHYL ACRYLATE COPOLYMER (1:1) TYPE A
FD&C BLUE NO. 2
FERRIC OXIDE YELLOW
GLYCERYL DIBEHENATE
SILICON DIOXIDE
MICROCRYSTALLINE CELLULOSE
HYPROMELLOSE, UNSPECIFIED
POVIDONE, UNSPECIFIED
Product Characteristics
Color green Score no score
Shape OVAL Size 12mm
Flavor Imprint Code RJ73
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:63304-927-30 30 TABLET, EXTENDED RELEASE in 1 BOTTLE None
2 NDC:63304-927-01 100 TABLET, EXTENDED RELEASE in 1 BOTTLE None
3 NDC:63304-927-05 500 TABLET, EXTENDED RELEASE in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA205689 08/17/2018
Labeler — Sun Pharmaceutical Industries, Inc (146974886)
Registrant — Sun Pharmaceutical Industries, Inc (146974886)
Establishment
Name Address ID/FEI Operations
Ohm Laboratories Inc. 184769029 MANUFACTURE (63304-924), MANUFACTURE (63304-925), MANUFACTURE (63304-926), MANUFACTURE (63304-927)
Establishment
Name Address ID/FEI Operations
Medichem S.A. 464043381 API MANUFACTURE (63304-924), API MANUFACTURE (63304-925), API MANUFACTURE (63304-926), API MANUFACTURE (63304-927)

Revised: 09/2021 Sun Pharmaceutical Industries, Inc

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2023. All Rights Reserved.